SCOPUS 정보 검색 플랫폼

Volumn 60, Issue 10, 2009, Pages 815-820

Does dilution have an impact on cosmetic results with BoNT/A? : CComplex-protein-free BoNT/A for treatment of glabella lines;Beeinflusst die Verdünnung das kosmetische Ergebnis von BoNT/A? : Komplexproteinfreies BoNT/A zur Behandlung der Glabellafalte

(6) Prager, W a Zschocke, I b Reich, C b Brocatti, L a Henning, K b Steinkraus, V a

a DERMATOLOGIKUM HAMBURG (Germany)

b SCIderm GmbH (Germany)

Author keywords

Botulinum neurotoxin type A; Dilution; Efficacy; Tolerability; Xeomin

Indexed keywords

BOTULINUM TOXIN A; CHLORIDE; COSMETIC;

ARTICLE; DILUTION; DRUG TOLERABILITY; ESTHETIC SURGERY; GLABELLAR LINE; HUMAN; WRINKLE;

ADOLESCENT; ADULT; AGED; BOTULINUM TOXIN TYPE A; CULTURE MEDIA, SERUM-FREE; FEMALE; HUMANS; MALE; MIDDLE AGED; SKIN AGING; SOLUBILITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70350038040 PISSN: 00178470 EISSN: None Source Type: Journal
DOI: 10.1007/s00105-009-1840-z Document Type: Article

Times cited : (12)

References (28)

1
- 4644310844
- 15280841 10.1016/j.jaad.2003.11.084
- Ascher B, Zakine B, Kestemont P et al 2004 J Am Acad Dermatol 51 223 15280841 10.1016/j.jaad.2003.11.084
- (2004) J Am Acad Dermatol , vol.51 , pp. 223
- Ascher, B.¹ Zakine, B.² Kestemont, P.³ Al, E.⁴

2
- 20444374407
- A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia
- DOI 10.1212/01.WNL.0000163767.99354.C3
- Benecke R, Jost WH, Kanovsky P et al 2005 Neurology 64 1949 15955951 10.1212/01.WNL.0000163767.99354.C3 1:CAS:528:DC%2BD2MXksVaisLc%3D (Pubitemid 40800714)
- (2005) Neurology , vol.64 , Issue.11 , pp. 1949-1951
- Benecke, R.¹ Jost, W.H.² Kanovsky, P.³ Ruzicka, E.⁴ Comes, G.⁵ Grafe, S.⁶

3
- 0035665381
- Botulinumtoxine: Wirksamkeit und antigenitat
- DOI 10.1055/s-2001-18954
- Bigalke H 2001 Klin Neurophysiol 32 210 10.1055/s-2001-18954 (Pubitemid 34013772)
- (2001) Klinische Neurophysiologie , vol.32 , Issue.4 , pp. 210-212
- Bigalke, H.¹

4
- 34047201026
- Comparative antigenicity of three preparations of botulinum neurotoxin type a in the rabbit
- Blümel J, Frevert J Schwaier A (2006) Comparative antigenicity of three preparations of botulinum neurotoxin type a in the rabbit. Neurotox Res 9(2-3):238
- (2006) Neurotox Res , vol.9 , Issue.2-3 , pp. 238
- Blümel, J.¹ Frevert, J.² Schwaier, A.³

5
- 33745318946
- Immunologic resistance after repeated botulinum toxin type A injections for facial rhytides [6]
- DOI 10.1097/01.iop.0000217703.80859.a3, PII 0000234120060500000032
- Borodic G 2006 Ophthal Plast Reconstr Surg 22 239 16714951 10.1097/01.iop.0000217703.80859.a3 (Pubitemid 44510175)
- (2006) Ophthalmic Plastic and Reconstructive Surgery , vol.22 , Issue.3 , pp. 239-240
- Borodic, G.¹

6
- 33845971560
- Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: Does it matter?
- DOI 10.1111/j.1524-4725.2006.32339.x
- Carruthers A, Carruthers J, Cohen J 2007 Dermatol Surg 33 S97 17241422 10.1111/j.1524-4725.2006.32339.x 1:CAS:528:DC%2BD2sXjvVSht7Y%3D (Pubitemid 46051407)
- (2007) Dermatologic Surgery , vol.33 , Issue.SUPPL. 1
- Carruthers, A.¹ Carruthers, J.² Cohen, J.³

7
- 7044227820
- Consensus recommendations on the use of botulinum toxin type A in facial aesthetics
- DOI 10.1097/01.PRS.0000144795.76040.D3
- Carruthers J, Fagien S, Matarasso SL 2004 Plast Reconstr Surg 114 1 10.1097/01.PRS.0000144795.76040.D3 (Pubitemid 40354480)
- (2004) Plastic and Reconstructive Surgery , vol.114
- Carruthers, J.¹ Fagien, S.² Matarasso, S.L.³

8
- 0142139322
- 12973229 10.1097/01.PRS.0000076504.79727.62
- Carruthers JD, Lowe NJ, Menter MA et al 2003 Plast Reconstr Surg 112 1089 12973229 10.1097/01.PRS.0000076504.79727.62
- (2003) Plast Reconstr Surg , vol.112 , pp. 1089
- Carruthers, J.D.¹ Lowe, N.J.² Menter, M.A.³ Al, E.⁴

9
- 0036621625
- 12063480 10.1067/mjd.2002.121356
- Carruthers JD, Lowe NJ, Menter MA et al 2002 J Am Acad Dermatol 46 840 12063480 10.1067/mjd.2002.121356
- (2002) J Am Acad Dermatol , vol.46 , pp. 840
- Carruthers, J.D.¹ Lowe, N.J.² Menter, M.A.³ Al, E.⁴

10
- 3042523236
- Carruthers JD, Lowe NJ, Menter MA et al 2004 J Clin Res 7 1
- (2004) J Clin Res , vol.7 , pp. 1
- Carruthers, J.D.¹ Lowe, N.J.² Menter, M.A.³ Al, E.⁴

11
- 2942604988
- Clinical presentation and management of antibody-induced failure of botulinum toxin therapy
- DOI 10.1002/mds.20022
- Dressler D 2004 Mov Disord 19 S92 15027060 10.1002/mds.20022 (Pubitemid 38967517)
- (2004) Movement Disorders , vol.19 , Issue.SUPPL. 8
- Dressler, D.¹

12
- 0033964204
- 10798896 10.1159/000008122 1:CAS:528:DC%2BD3cXpt1ejsg%3D%3D
- Dressler D, Rothwell JC 2000 Eur Neurol 43 13 10798896 10.1159/000008122 1:CAS:528:DC%2BD3cXpt1ejsg%3D%3D
- (2000) Eur Neurol , vol.43 , pp. 13
- Dressler, D.¹ Rothwell, J.C.²

13
- 0036117664
- Botulinum toxin in upper limb spasticity after acquired brain injury: A randomized trial comparing dilution techniques
- DOI 10.1097/00002060-200205000-00007
- Francisco GE, Boake C, Vaughn A 2002 Am J Phys Med Rehabil 81 3545 10.1097/00002060-200205000-00007 (Pubitemid 34412072)
- (2002) American Journal of Physical Medicine and Rehabilitation , vol.81 , Issue.5 , pp. 355-363
- Francisco, G.E.¹ Boake, C.² Vaughn, A.³

14
- 0031239673
- Botulinum a toxin therapy: Neutralizing and nonneutralizing antibodies - Therapeutic consequences
- DOI 10.1006/exnr.1997.6580
- Göschel H, Wohlfarth K, Frevert J et al 1997 Exp Neurol 147 96 9294406 10.1006/exnr.1997.6580 (Pubitemid 27402446)
- (1997) Experimental Neurology , vol.147 , Issue.1 , pp. 96-102
- Goschel, H.¹ Wohlfarth, K.² Frevert, J.³ Dengler, R.⁴ Bigalke, H.⁵

15
- 8144220875
- Effect of volume and concentration on the diffusion of botulinum exotoxin A
- DOI 10.1001/archderm.140.11.1351
- Hsu TSJ, Dover JS, Arndt KA 2004 Arch Dermatol 140 1351 15545544 10.1001/archderm.140.11.1351 1:CAS:528:DC%2BD2cXhtVKnsrrN (Pubitemid 39473635)
- (2004) Archives of Dermatology , vol.140 , Issue.11 , pp. 1351-1354
- Hsu, T.S.J.¹ Dover, J.S.² Arndt, K.A.³

16
- 34047207959
- Botulinum neurotoxin type A free of complexing proteins (XEOMIN®) in focal dystonia
- DOI 10.2165/00003495-200767050-00003
- Jost WH, Bl?mel J, Grafe S 2007 Drugs 67 669 17385940 10.2165/00003495-200767050-00003 1:CAS:528:DC%2BD2sXlsVCmtbw%3D (Pubitemid 46535642)
- (2007) Drugs , vol.67 , Issue.5 , pp. 669-683
- Jost, W.H.¹ Blumel, J.² Grafe, S.³

17
- 70350025902
- Khorram R 2006 Plastische Chirurgie 6 55
- (2006) Plastische Chirurgie , vol.6 , pp. 55
- Khorram, R.¹

18
- 0031724961
- 9834735 10.1016/S1076-0512(98)00178-2 1:STN:280:DyaK1M%2FltFyjsg%3D%3D
- Klein AW 1998 Dermatol Surg 24 1179 9834735 10.1016/S1076-0512(98)00178-2 1:STN:280:DyaK1M%2FltFyjsg%3D%3D
- (1998) Dermatol Surg , vol.24 , pp. 1179
- Klein, A.W.¹

19
- 33845982231
- Antibody-induced failure of botulinum toxin type A therapy in a patient with masseteric hypertrophy
- DOI 10.1111/j.1524-4725.2006.32340.x
- Lee SK 2007 Dermatol Surg 33 S105 17278332 10.1111/j.1524-4725.2006. 32340.x 1:CAS:528:DC%2BD2sXjvVSht7c%3D (Pubitemid 46051408)
- (2007) Dermatologic Surgery , vol.33 , Issue.SUPPL. 1
- Lee, S.-K.¹

20
- 18244375282
- 15841623 1:CAS:528:DC%2BD28XhtFyhu7nM
- Lowe NJ, Ascher B, Heckmann M et al 2005 Dermatol Surg 31 257 15841623 1:CAS:528:DC%2BD28XhtFyhu7nM
- (2005) Dermatol Surg , vol.31 , pp. 257
- Lowe, N.J.¹ Ascher, B.² Heckmann, M.³ Al, E.⁴

21
- 0036521580
- 12079632 10.1080/14764170260030117
- Lowe NJ, Yamauchi PS, Lask GP et al 2002 J Cosmet Laser Ther 4 15 12079632 10.1080/14764170260030117
- (2002) J Cosmet Laser Ther , vol.4 , pp. 15
- Lowe, N.J.¹ Yamauchi, P.S.² Lask, G.P.³ Al, E.⁴

22
- 70350023936
- Maack M, Kr?ger J, Bayrhammer J et al 2007 Dtsch Dermatologe 55 562
- (2007) Dtsch Dermatologe , vol.55 , pp. 562
- Maack, M.¹ Krger, J.² Bayrhammer, J.³

23
- 34249330707
- Prager W, Zschocke I, Turnbull K, Steinkraus V 2007 Kosmetische Medizin 2 81
- (2007) Kosmetische Medizin , vol.2 , pp. 81
- Prager, W.¹ Zschocke, I.² Turnbull, K.³ Steinkraus, V.⁴

24
- 32044437587
- Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm
- DOI 10.1007/s00702-005-0323-3
- Roggenkamper P, Jost WH, Bihari K et al 2006 J Neural Transm 113 303 15959841 10.1007/s00702-005-0323-3 1:STN:280:DC%2BD28%2Fmsl2htg%3D%3D (Pubitemid 43201097)
- (2006) Journal of Neural Transmission , vol.113 , Issue.3 , pp. 303-312
- Roggenkamper, P.¹ Jost, W.H.² Bihari, K.³ Comes, G.⁴ Grafe, S.⁵

25
- 0013279761
- Shin HI, Han TR, Seo KI 2000 J Korean Acad Phys Med Rehabil 28 67
- (2000) J Korean Acad Phys Med Rehabil , vol.28 , pp. 67
- Shin, H.I.¹ Han, T.R.² Seo, K.I.³

26
- 33846207489
- Konsensusempfehlungen zum gebrauch von Botulinumtoxin A in der asthetischen medizin - Klinische erfahrungen und empfehlungen langjahriger anwender
- DOI 10.1111/j.1610-0387.2007.06204.x
- Sommer Boris, Bergfeld D, Sattler G 2007 JDDG 5 S1 17229195 10.1111/j.1610-0387.2007.06204.x (Pubitemid 46092874)
- (2007) JDDG - Journal of the German Society of Dermatology , vol.5 , Issue.SUPPL.1
- Sommer, B.¹ Bergfeld, D.² Sattler, G.³

27
- 33845999297
- Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis
- Trinidade de Almeida AR, Marques E, de Almeide J et al (2007) Pilot study comparing the diffusion of two formulations of botulinum toxin type A in patients with forehead hyperhidrosis. Dermatol Surg 33 (1 Spec NO.):S37-S43
- (2007) Dermatol Surg , vol.33 , Issue.1 SPEC.
- Trinidade De Almeida, A.R.¹ Marques, E.² De Almeide, J.³ Al, E.⁴

28
- 34147222256
- Neurophysiological double-blind trial of a botulinum neurotoxin type A free of complexing proteins
- DOI 10.1097/01.WNF.0000240951.18821.50, PII 0000282620070300000003
- Wohlfarth K, Müller C, Sassin I et al 2007 Clin Neuropharmacol 30 86 17414940 10.1097/01.WNF.0000240951.18821.50 1:CAS:528:DC%2BD2sXjvVKhsrk%3D (Pubitemid 46581201)
- (2007) Clinical Neuropharmacology , vol.30 , Issue.2 , pp. 86-94
- Wohlfarth, K.¹ Muller, C.² Sassin, I.³ Comes, G.⁴ Grafe, S.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.